Đang chuẩn bị liên kết để tải về tài liệu:
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanced breast cancer (ABC) patients pre-treated with anthracycline and taxane. | Multicentre phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

TÀI LIỆU LIÊN QUAN

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: A Spanish, multicentre, open-label, single arm phase II study

The WIRE study a phase II, multi-arm, multicentre, non-randomised window-ofopportunity clinical trial platform using a Bayesian adaptive design for proof-ofmechanism of novel treatment strategies in operable renal cell cancer – a study protocol

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-IMETRY): Protocol for a multicentre UK single arm phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

CRITICS-II: A multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Beta-hydroxy beta-methylbutyrate/arginine/ glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: An open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Preoperative stereotactic radiosurgery for brain metastases: The STEP study protocol for a multicentre, prospective, phase-II trial
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.